SEC Company Response from SciSparc Ltd. (SPRC) (CIK 0001611746) (SPRC) — Dec 15, 2016
SciSparc Ltd. (SPRC) (CIK 0001611746)
Date: Dec. 15, 2016 · CIK: 0001611746 · Accession: 0001213900-16-019456
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-214458
Letter
Therapix Biosciences Ltd.
5 Azrieli Center (Square Tower)
Tel-Aviv 6702501, Israel
December 15, 2016
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE: Therapix Biosciences Ltd. (CIK: 0001611746)
Registration Statement No. 333-214458 on Form F-1 (the “Registration Statement”)
Ladies and Gentlemen:
Therapix Biosciences Ltd. hereby withdraws its request submitted on December 13, 2016, for acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended.
Very truly yours,
Therapix Biosciences Ltd.
Show Raw Text
CORRESP
1
filename1.htm
Therapix Biosciences Ltd.
5 Azrieli Center (Square Tower)
Tel-Aviv 6702501, Israel
December 15, 2016
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE:
Therapix Biosciences Ltd. (CIK: 0001611746)
Registration Statement No. 333-214458 on Form F-1 (the “Registration Statement”)
Ladies and Gentlemen:
Therapix Biosciences
Ltd. hereby withdraws its request submitted on December 13, 2016, for acceleration of the effectiveness of the above-referenced
Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended.
Very truly yours,
Therapix Biosciences Ltd.
By:
/s/ Dr. Elran Haber
Dr. Elran Haber, Chief Executive Officer